Kelly Werner

Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma

Ola Landgren, Malin Hultcrantz, Benjamin Diamond et al. · JAMA Oncology · 2021 · 120 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Weekly Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab (wKRd-D) Combination Therapy Provides Unprecedented MRD Negativity Rates in Newly Diagnosed Multiple Myeloma: A Clinical and Correlative Phase 2 Study

Ola Landgren, Malin Hultcrantz, Alexander M. Lesokhin et al. · Blood · 2019 · 40 citations

Medicine, Oncology, Pharmacotherapy +13

Ethical considerations in the use of artificial womb/placenta technology

Kelly Werner, Mark R. Mercurio · Seminars in Perinatology · 2021 · 25 citations

Public Health, Maternal Health, Obstetrics +14

Using MALDI-TOF mass spectrometry in peripheral blood for the follow up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapy

Marion Eveillard, Neha Korde, Amanda Ciardiello et al. · Clinica Chimica Acta · 2021 · 18 citations · Full text

Medicine, Immunology, Oncology +17

Conflicts of interest policies for authors, peer reviewers, and editors of bioethics journals

Zubin Master, Kelly Werner, Elise Smith et al. · AJOB Empirical Bioethics · 2018 · 11 citations · Full text

Law, Biomedical Sciences, Bioethics +14